Based on PubMed | Can persistent tingling be a symptom of endometrial cancer, and when should it prompt medical evaluation?

Persistent tingling and endometrial cancer: what’s known

• Persistent tingling (pins-and-needles) or numbness is not a typical presenting symptom of endometrial (uterine) cancer itself. The most common warning signs of endometrial cancer are abnormal uterine bleeding (especially postmenopausal bleeding), pelvic pain, pain with sex, difficulty or pain with urination, and, in later stages, unexplained weight loss. ^{[1] [2]}
• Tingling and numbness are more commonly linked to the treatments used for endometrial cancer especially chemotherapy with drugs like paclitaxel and platinum agents which can damage peripheral nerves and cause peripheral neuropathy in the hands and feet. ^{[3] [4]}
• Rarely, nerve symptoms (including painful tingling or numbness) can occur as part of a paraneoplastic neurological syndrome an immune‑mediated effect of a tumor even before or at the time of diagnosis; this has been reported in only sporadic endometrial cancer cases and is considered uncommon. ^{[5] [6]}

How cancer treatments can cause tingling

• Standard regimens for recurrent or metastatic endometrial cancer that include paclitaxel and carboplatin commonly list “nerve damage (peripheral neuropathy)” with tingling, numbness, or pain in hands and feet as expected side effects. ^{[3] [7]}
• These resources advise people to promptly report new or worsening tingling or numbness during treatment so doses can be adjusted and safety strategies can be used to prevent injury. ^{[3] [4]}

Rare cancer-related neurological causes

• Paraneoplastic peripheral neuropathy is a rare immune-related complication that can present with asymmetric sensory and motor symptoms and painful paresthesias; only isolated cases are linked to endometrial carcinoma. ^{[5] [8]}
• Paraneoplastic neurological syndromes overall are uncommon in uterine cancers, but reported types include sensory neuropathies and sensory–motor neuropathies; their recognition can help reveal an otherwise hidden cancer or signal recurrence. ^{[8] [9]}

When tingling should prompt medical evaluation

• If you are on chemotherapy or immunotherapy for endometrial cancer, new or worsening tingling, numbness, burning, or weakness should be reported to your oncology team, as recommended in patient treatment guides for these regimens. ^{[3] [7]}
• Independent of cancer status, medical guidance for adults suggests seeking urgent care if numbness or tingling begins suddenly, follows an injury, or occurs with red-flag neurologic symptoms like weakness, trouble speaking, confusion, severe headache, or dizziness. ^{[10] [11]}
• For gradual or persistent tingling that affects daily activities, spreads, involves both sides, or comes and goes, scheduling a non-urgent medical visit is advisable to evaluate common causes (nerve compression, metabolic issues, medication effects) and less common ones. ^{[12] [13]}

Practical next steps

• If you are receiving endometrial cancer therapy and notice tingling or numbness, consider tracking onset, body areas involved, severity, and triggers, then share with your oncology team to discuss dose adjustments, symptom control, and safety tips (for example, fall prevention, skin protection). ^{[3] [7]}
• If you have tingling without a known cancer diagnosis and also have any uterine cancer warning signs especially postmenopausal bleeding or abnormal bleeding arranging a gynecologic evaluation is important because early assessment improves outcomes. ^{[1] [2]}

Summary

• Persistent tingling is not a hallmark symptom of endometrial cancer itself, but it is a well-recognized side effect of common endometrial cancer treatments such as paclitaxel- and platinum-based chemotherapy. ^{[3] [4]}
• Very rarely, tingling can occur due to paraneoplastic neuropathy associated with endometrial carcinoma, but such cases are uncommon and documented mainly as individual reports. ^{[5] [8]}
• Seek urgent care for tingling with sudden onset or neurologic red flags, and inform your care team promptly if symptoms arise during cancer therapy; otherwise, schedule evaluation for persistent or spreading symptoms to determine the cause and appropriate management. ^{[10] [12] [3]}

---

Quick reference: common endometrial cancer symptoms vs. tingling

• Common endometrial cancer symptoms: abnormal uterine bleeding (including after menopause), pelvic pain, pain with sex, difficulty or pain with urination, and late unexplained weight loss. ^{[1] [2]}
• Tingling/numbness: typically treatment-related neuropathy with paclitaxel/carboplatin regimens; report to care team. ^{[3] [7]}
• Rare cause: paraneoplastic neuropathy reported only sporadically in endometrial cancer. ^{[5] [8]}